(NewsDirect)
Sona Nanotech Inc. (CSE: SONA, OTCQB:SNANF) CEO David Regan speaks to Thomas Warner from Proactive abouthis ambitious plans for the Canadian company's proprietary goldnanorods.
He says that Sona Nanotech is currently "buildinga mountain of data" to support the potential use of its technologyin innovative cancer treatments, having recently announced that it hadreceived the third set of results of an independent assessment of itsnanorods from the U.S. National Cancer Institute’s NanotechnologyCharacterization Laboratory (“NCL”).
ContactDetails
Proactive United States
ProactiveUnited States
+1 347-449-0879
Copyright (c) 2023 TheNewswire - All rights reserved.